Synthesis and Biological Evaluation of C6‐ O ‐Glycosylated α‐Mangostin Derivatives Against Methicillin‐Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity
ChemMedChem · 14.07.2026 · 21 (13)
DOI: 10.1002/cmdc.70366 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 05.07.2026. Verfasst von Wenchong Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Xanthones, Anti-Bacterial Agents, Cell Membrane. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, NKRDPC.
Abstract (Originalsprache)
Methicillin‐resistant Staphylococcus aureus (MRSA) remains a major global health threat, driving demand for antibacterial agents with robust efficacy and low propensity for resistance. The natural xanthone α‐mangostin (α‐MG) shows potent anti‐MRSA activity via membrane disruption, but its high hydrophobicity and hemolytic liability limit therapeutic potential. Here, we designed and synthesized a focused series of C6‐ O ‐glycosylated α‐MG derivatives ( Y‐1–Y‐15 ) bearing structurally diverse mono‐ and disaccharides to tune amphiphilicity and improve bacterial‐versus‐host selectivity. Among them, Y‐3 ( L ‐gulose conjugate) retained strong activity against both methicillin‐susceptible S. aureus and MRSA (MIC = 2 μg/mL), while markedly reducing red blood cell lysis (HC 50 = 48.20 μg/mL) and improving the selectivity index (SI = 24.10). Mechanistic assays showed that Y‐3 rapidly permeabilized and depolarized bacterial membranes. In phospholipid antagonism experiments, anionic bacterial lipids (cardiolipin and phosphatidylglycerol) reduced Y‐3 activity more strongly than phosphatidylcholine, supporting preferential interaction with bacterial‐type membranes. In a murine MRSA wound infection model, topical Y‐3 reduced bacterial burden and accelerated wound healing compared with the vehicle and α‐MG. Together, this study identifies C6 glycosylation as a practical strategy to decouple the antibacterial efficacy of α‐MG from host membrane toxicity and support Y‐3 as a lead for topical anti‐MRSA development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
- Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
- Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou, China.
ORCID-Profile: Shengyi Wang, Wen Zhou
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- NKRDPC
Zitieren
APA
Ye, W., Fan, C., Zhou, T., Wang, X., Wang, C., Zhang, K., Wang, S., & Zhou, W. (2026). Synthesis and Biological Evaluation of C6‐ O ‐Glycosylated α‐Mangostin Derivatives Against Methicillin‐Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70366
Vancouver
Ye W, Fan C, Zhou T, Wang X, Wang C, Zhang K, et al. Synthesis and Biological Evaluation of C6‐ O ‐Glycosylated α‐Mangostin Derivatives Against Methicillin‐Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70366
BibTeX
@article{Ye2026,
author = {Ye, Wenchong and Fan, Chuangchuang and Zhou, Tiantian and Wang, Xiaoyang and Wang, Chunmei and Zhang, Keyu and Wang, Shengyi and Zhou, Wen},
title = {Synthesis and Biological Evaluation of C6‐ O ‐Glycosylated α‐Mangostin Derivatives Against Methicillin‐Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {13},
doi = {10.1002/cmdc.70366}
}
EUVIMED